ROSEN, GLOBAL INVESTOR COUNSEL, Urges Brainstorm Cell Therapeutics Investors to Act Before Deadline in Securities Lawsuit

ROSEN, a globally recognized law firm, reminds investors of Brainstorm Cell Therapeutics Inc. BCLI of the upcoming deadline to apply for the role of lead plaintiff in a securities class action lawsuit that was initiated by the firm. This lawsuit was filed on behalf of shareholders who purchased shares of BCLI during a specified time frame and experienced financial losses. The lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Understanding the Case Against Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc., a biotechnology entity specializing in the novel field of autologous cell therapies for neurodegenerative diseases, is facing a class action lawsuit alleging that the company disseminated misleading information which adversely affected investor trust and the value of their investments in the company's stock BCLI. The trial aims to recuperate damages for Brainstorm shareholders under federal securities laws.

Important Deadlines and Participation Information

Investors in Brainstorm Cell Therapeutics Inc. who incurred losses during the class period are urged to contact ROSEN's counsel to learn more about their rights and to ensure that they are represented adequately before the crucial deadline. Comprising of seasoned litigators, ROSEN's team emphasizes the importance of investors potentially acting as the lead plaintiff, which involves a selection by the court and is not a role exclusive to large investors.

About Brainstorm Cell Therapeutics Inc.

Headquartered in New York, New York, Brainstorm Cell Therapeutics Inc. BCLI is a biotechnology company committed to the pursuit of developing cell therapy treatments for debilitating neurodegenerative disorders. Their passion for innovative therapeutic approaches showcases the company's dedication to addressing challenging medical conditions with a significant unmet need.

Investment, Legal, ClassAction